Stage 4 Lung Cancer Survivor Thrives After Rare Diagnosis

In early 2020, Summer Farmen, then 44, experienced severe shortness of breath and persistent tiredness. Initially dismissed as less serious, her symptoms worsened, leading to an emergency room visit where doctors drained two liters of fluid from her lungs. She was diagnosed with stage four lung cancer, a condition with a typically short survival expectancy.

Farmen's diagnosis, however, was linked to a rare ALK-positive gene abnormality. This specific subtype of lung cancer is highly treatable with precision medicine, such as tyrosine kinase inhibitors, which block tumor growth. This offered a significant turning point from an otherwise terminal prognosis.

Over six years later, now 50, Farmen is thriving and has become a vocal patient advocate. She actively works with organizations like Alk Positive Inc. to fund research and provide support resources for patients and caregivers. Her advocacy focuses on empowering patients to be active participants in their treatment decisions.

Farmen emphasizes that despite her survival and thriving, the journey involves ongoing physical and emotional challenges, with regular scans to monitor her stage four diagnosis. She cherishes her life, celebrating milestones like her 50th birthday and advocating for the privilege of growing older.